期刊档案 · PEDIATRICS

Progress in Pediatric Cardiology

ISSN 1058-9813 · eISSN 1558-1519 · Elsevier

Progress in Pediatric Cardiology 中科院 医学 4区(2025 年升级版),影响因子 0.4(官网公布),混合开放获取,APC 约 2,670 美元,出版商公布投稿到接收约 87 天,2025 年发文 94 篇,ESCI、Scopus 收录。

影响因子0.4期刊官网公布的最新值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 4区
审稿周期87 天出版商公布的投稿到接收时间
版面费2,670 USD混合期刊,仅开放获取发表时收取
录用比例—暂无反馈
年发文量94 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Progress in Pediatric Cardiology 由 Elsevier 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Congenital Heart Disease Studies、Cardiac Structural Anomalies and Repair、Mechanical Circulatory Support Devices 等主题的论文,这 3 个主题约占 32.9%,主导子领域为 Cardiology and Cardiovascular Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)

Affiliated with the Society of Pediatric Cardiology Training Program DirectorsProgress in Pediatric Cardiology (PPC) provides a rich mix of original research, reviews, experienced opinion, and debate for academics, clinicians, healthcare managers, policymakers and patients on all aspects of the understanding, management, and improvement of pediatric and congenital cardiovascular diseases.PPC focuses on all aspects of complex cardiovascular issues in children and patients with congenital heart disease, merging pathophysiology, prevention, treatment, nursing, outcomes, quality improvement, medical education, adult congenital heart disease, genetics, and advocacy. PPC addresses a critical void by combining a commitment to publish works of scrupulous, scientific merit across wide-ranging domains, recognizing the central questions and values uniting the professions involved in the care of pediatric and congenital heart disease.Please see the Guide for Authors for further details.

摘自期刊官网 Aims & Scope

研究方向(LetPub):PEDIATRICS

主编 Steven E. Lipshultz出版商官网

编委会国家分布:未见中国大陆编委;主要国家 美国 36、加拿大 4、巴基斯坦 4、英国 2、澳大利亚 2(共 48 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Congenital Heart Disease StudiesMedicine21%
  2. Cardiac Structural Anomalies and RepairMedicine6.3%
  3. Mechanical Circulatory Support DevicesEngineering5.6%
  4. Cardiac Arrhythmias and TreatmentsMedicine5.4%
  5. Coronary Artery AnomaliesMedicine5.3%
  6. Kawasaki Disease and Coronary ComplicationsMedicine4.1%
  7. Cardiac Valve Diseases and TreatmentsMedicine3.9%
  8. Cardiomyopathy and Myosin StudiesMedicine3.8%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类儿科PEDIATRICS4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 4 区
类别学科分区
大类医学4 区
小类儿科PEDIATRICS4 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
0.4出版商官网 ·
CiteScore 2026-06
0.8LetPub ·
CiteScore(出版商公布)
0.8出版商官网 ·
SJR 2026-06
0.17LetPub ·
SNIP 2026-06
0.22LetPub ·
h-index
44OpenAlex ·
i10-index
300OpenAlex ·
两年平均被引
0.44OpenAlex ·
自引率
0%LetPub ·
Gold OA 文章占比
14.57%LetPub ·

发文规模

年文章数
90LetPub ·

逐年发文量 OpenAlex 统计 · 累计 2,092 篇 · 当年数据不完整

年份发文量其中 OA被引
202671165
2025941437
20241012774
202358357
20227811206
20219619360

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

出版商公布的审稿周期 期刊官网自述数据

87 天投稿到接收

出版商统计口径以官网为准;本刊近 24 个月的文章日期尚未获得,因此以官方数据为准。

各来源数据

投稿到首次决定
8 天出版商官网 ·
外审后首次决定
43 天出版商官网 ·
投稿到接收
87 天出版商官网 ·
接收到发表
2 天出版商官网 ·
评审方式
单盲同行评审出版商官网

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

混合开放获取LetPub

订阅期刊,作者可付费选择开放获取发表。

来源文章处理费费用减免许可证观测时间
OpenAlexUSD 2,670 / EUR 2,500 / GBP 2,140 / JPY 331,160——
出版商官网USD 2,320——

混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点5 项,摘自作者指南
摘要
≤ 250 词
关键词
≥ 4 个
参考文献格式
AMA 格式
Highlights(研究亮点)
必须提供
图文摘要
可选
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型17 种,含篇幅限制
  1. case reportPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…正文 ≤ 2,000 词 · 摘要 ≤ 200 词
  2. case reports3. Case Reports: Case Reports provide a concise description of a particular condition that offers insights into diagnosis or clinical management.未说明篇幅
  3. commentaryPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…正文 ≤ 2,000 词
  4. correspondencePPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  5. editorialPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…正文 ≤ 1,500 词 · 摘要 ≤ 500 词
  6. letters to the editorPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  7. meta-analysisPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  8. narrative reviewPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  9. opinionPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  10. original researchPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  11. original research articlePPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  12. reviewPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…正文 ≤ 4,000 词 · 摘要 ≤ 300 词
  13. review articlePPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  14. reviews2. Reviews: PPC publishes Systematic Reviews/Meta-Analyses (SR/MA) and Narrative Reviews.未说明篇幅
  15. short communicationPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
  16. special issue articles7. Special Issue Articles: PPC periodically publishes special thematic issues devoted to areas of current interest to the pediatric and congenital cardiology co…未说明篇幅
  17. systematic reviewPPC seeks to publish manuscripts that 1) describe significant and novel findings and 2) advance knowledge in the field via original research articles, reviews o…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、预印本
AI 使用 Declaration of generative AI use

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Group authorship

团体署名须在投稿时于标题页声明,提交作者应在投稿系统的“Collaborative Author Groups”中填写该团体。 模型中文摘要

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

所有作者必须披露可能不当影响或偏倚其工作的与他人或组织的财务和个人关系。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

原文 ↗出版商官网 ·
出版伦理

作者必须遵守Elsevier出版伦理政策中规定的伦理准则。 模型中文摘要

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

原文 ↗出版商官网 ·
许可与版权 License options

作者将获得开放获取用户许可选项,建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

原文 ↗出版商官网 ·
开放获取 Open access

本刊提供开放获取选项,详见开放获取信息页面。 模型中文摘要

We refer you to our open access information page to learn about open access options for this journal.

原文 ↗出版商官网 ·
同行评审 Peer review

本刊采用单盲同行评审,稿件通常至少送两名审稿人进行独立专家评估,录用与否由编辑决定。 模型中文摘要

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

原文 ↗出版商官网 ·
预印本 Preprints

作者可按Elsevier文章共享政策分享预印本,分享预印本不计作先前发表,本刊还提供SSRN免费预印本发布服务。 模型中文摘要

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Elsevier
ISSN
1058-9813
电子版 ISSN
1558-1519
官方链接

常见问题

关于 Progress in Pediatric Cardiology 的常见问题

Progress in Pediatric Cardiology 是中科院几区期刊?

2025 年升级版分区表中,Progress in Pediatric Cardiology 为医学 4区,小类 儿科 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。

Progress in Pediatric Cardiology 的影响因子是多少?

期刊官网公布的影响因子为 0.4,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 0.8,h-index 为 44。

Progress in Pediatric Cardiology 的审稿周期多长?

出版商公布的投稿到接收时间约为 87 天。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Progress in Pediatric Cardiology 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 250 词;关键词:≥ 4 个;参考文献格式:AMA 格式;Highlights:必须提供;图文摘要:可选。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Progress in Pediatric Cardiology 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 48 位编委中,没有中国大陆学者;人数最多的国家是 美国(36 位)、加拿大(4 位)、巴基斯坦(4 位)。统计按编委会页面列出的机构国家计,仅供参考。

Progress in Pediatric Cardiology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Progress in Pediatric Cardiology 被 ESCI、Scopus 收录。

Progress in Pediatric Cardiology 是开放获取期刊吗?版面费多少?

Progress in Pediatric Cardiology 为混合开放获取。选择开放获取发表时APC 约 2,670 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。